Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 3, 2015, Pages 295-306

  Waschki, Benjamin ^a,b   Kirsten, Anne M ^a   Holz, Olaf ^b   Mueller, Kai Christian ^a   Schaper, Miriam ^a   Sack, Anna Lena ^a   Meyer, Thorsten ^c   Rabe, Klaus F ^b   Magnussen, Helgo ^a   Watz, Henrik ^a  

^a GERMAN CENTER FOR LUNG RESEARCH   (Germany)

^b FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Exercise; Motor activity; Musculoskeletal diseases; Pulmonary disease; Quality of life

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENERGY EXPENDITURE; EXERCISE; FAT FREE MASS; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE MASS; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; WALKING; ANALYSIS OF VARIANCE; ENERGY METABOLISM; PATHOPHYSIOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE;

ANALYSIS OF VARIANCE; BRONCHITIS, CHRONIC; COHORT STUDIES; DISEASE PROGRESSION; ENERGY METABOLISM; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84938873999     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201501-0081OC     Document Type: Article

References (51)

1. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187: 347-365.
2. ZuWallack R. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD 2007;4:293-297.
3. Roche N. Activity limitation: a major consequence of dyspnoea in COPD. Eur Respir Rev 2009;18:54-57.
4. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J 2009;33:262-272.
5. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, Benzo R, Andre D, Weisman I, Decramer M. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010;104:1005-1011.
6. Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, Smith C, Man WD, Tal-Singer R, Edwards LD, et al. Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 2012;106:522-530.
7. Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, Walsh SL, Bloch SA, Sidhu PS, Hart N, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012;40:1115-1122.
8. Van Remoortel H, Hornikx M, Demeyer H, Langer D, Burtin C, Decramer M, Gosselink R, Janssens W, Troosters T. Daily physical activity in subjects with newly diagnosed COPD. Thorax 2013;68:962-963.
9. Van Remoortel H, Hornikx M, Langer D, Burtin C, Everaerts S, Verhamme P, Boonen S, Gosselink R, Decramer M, Troosters T, et al. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;189:30-38.
10. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006;61:772-778.
11. Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM; Estudi del Factors de Risc d'Aguditzacióde la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003;58:100-105.
12. Waschki B, Kirsten A, Holz O, Müller KC, Meyer T, Watz H, Magnussen H. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011;140: 331-342.
13. Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, Galera R, Villasante C. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012;142: 338-346.
14. Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, Vaes AW, Puhan MA, Jehn M, Polkey MI, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J 2014;44:1521-1537.
15. Vaes AW, Garcia-Aymerich J, Marott JL, Benet M, Groenen MT, Schnohr P, Franssen FM, Vestbo J, Wouters EF, Lange P, et al. Changes in physical activity and all-cause mortality in COPD. Eur Respir J 2014;44:1199-1209.
16. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012;379:1341-1351.
17. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008;177:743-751.
18. Gimeno-Santos E, Frei A, Steurer-Stey C, de Batlle J, Rabinovich RA, Raste Y, Hopkinson NS, Polkey MI, van Remoortel H, Troosters T, et al.; PROactive consortium. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax 2014;69:731-739.
19. Waschki B, Schaper M, Sack AL, Holz O, Kirsten A, Meyer T, Rabe KF, Magnussen H, Watz H. Decrease of physical activity in patients with COPD in the course of the disease [abstract]. Eur Respir J 2012;40: 548s.
20. Patel SA, Benzo RP, Slivka WA, Sciurba FC. Activity monitoring and energy expenditure in COPD patients: a validation study. COPD 2007;4:107-112.
21. St-Onge M, Mignault D, Allison DB, Rabasa-Lhoret R. Evaluation of a portable device to measure daily energy expenditure in free-living adults. Am J Clin Nutr 2007;85:742-749.
22. Hill K, Dolmage TE, Woon L, Goldstein R, Brooks D. Measurement properties of the SenseWear armband in adults with chronic obstructive pulmonary disease. Thorax 2010;65:486-491.
23. Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, Wilson F, Rabinovich R, Vogiatzis I, Hopkinson NS, et al.; PROactive consortium. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 2012;7:e39198.
24. Rabinovich RA, Louvaris Z, Raste Y, Langer D, Van Remoortel H, Giavedoni S, Burtin C, Regueiro EM, Vogiatzis I, Hopkinson NS, et al.; PROactive Consortium. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 2013;42: 1205-1215.
25. Human energy requirements: report of a joint FAO/WHO/UNU Expert Consultation. Food Nutr Bull 2005;26:166.
26. Rutten EP, Spruit MA, Wouters EF. Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD. Respir Med 2010;104:91-98.
27. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sørensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83.
28. Cohen J. Statistical power analysis for the behavioural sciences. New York: Academic Press; 1969.
29. O'Donnell DE, Laveneziana P. Dyspnea and activity limitation in COPD: mechanical factors. COPD 2007;4:225-236.
30. Agarwal V, Tetenta S, Bautista J, ZuWallack R, Lahiri B. Longitudinal changes in directly measured physical activity in patients with chronic obstructive pulmonary disease: the trajectory of change. J Cardiopulm Rehabil Prev 2012;32:292-295.
31. Durheim MT, Smith PJ, Babyak MA, Mabe SK, Martinu T, Welty-Wolf KE, Emery CF, Palmer SM, Blumenthal JA. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group. Ann Am Thorac Soc 2015;12: 349-356.
32. Elia M, Ritz P, Stubbs RJ. Total energy expenditure in the elderly. Eur J Clin Nutr 2000;54:S92-S103.
33. Luhrmann PM, Bender R, Edelmann-Schafer B, Neuhauser-Berthold M. Longitudinal changes in energy expenditure in an elderly German population: a 12-year follow-up. Eur J Clin Nutr 2009; 63:986-992.
34. Rothenberg EM, Bosaeus IG, Steen BC. Energy expenditure at age 73 and 78-a five year follow-up. Acta Diabetol 2003;40: S134-S138.
35. Dwyer T, Ponsonby AL, Ukoumunne OC, Pezic A, Venn A, Dunstan D, Barr E, Blair S, Cochrane J, Zimmet P, et al. Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study. BMJ 2011;342:c7249.
36. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007; 175:458-463.
37. Pelkonen M, Notkola IL, Lakka T, Tukiainen HO, Kivinen P, Nissinen A. Delaying decline in pulmonary function with physical activity: a 25-year follow-up. Am J Respir Crit Care Med 2003;168:494-499.
38. Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Perez-Izquierdo J, Aizpiri S, Aguirre U, Capelastegui A. Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 2010;36:292-300.
39. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972-977.
40. van Gestel AJ, Clarenbach CF, Stowhas AC, Rossi VA, Sievi NA, Camen G, Russi EW, Kohler M. Predicting daily physical activity in patients with chronic obstructive pulmonary disease. PLoS One 2012;7:e48081.
41. Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PM, Pinto-Plata V, Celli BR, Tal-Singer R, Wouters EF; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 2010;104: 849-857.
42. Frisk B, Espehaug B, Hardie JA, Strand LI, Moe-Nilssen R, Eagan TM, Bakke PS, Thorsen E. Physical activity and longitudinal change in 6-min walk distance in COPD patients. Respir Med 2014;108:86-94.
43. Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention. COPD 2008;5:235-256.
44. Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Moxham J, Polkey MI. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007;8:25.
45. van den Borst B, Koster A, Yu B, Gosker HR, Meibohm B, Bauer DC, Kritchevsky SB, Liu Y, Newman AB, Harris TB, et al. Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax 2011;66:961-969.
46. Magnussen H, Watz H. Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities. Proc Am Thorac Soc 2009;6:648-651.
47. Garcia-Aymerich J, Serra I, Gómez FP, Farrero E, Balcells E, Rodŕiguez DA, de Batlle J, Gimeno E, Donaire-Gonzalez D, Orozco-Levi M, et al.; Phenotype and Course of COPD Study Group. Physical activity and clinical and functional status in COPD. Chest 2009;136:62-70.
48. Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008; 454:463-469.
49. Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012;7:e37483.
50. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543-1554.
51. Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis 2012;7:95-99.